Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback